Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.56 USD | -1.92% | -2.17% | -8.22% |
May. 23 | Supernus Pharmaceuticals Reports 'Clinical Utility' From Epilepsy Treatment Study | MT |
May. 23 | Transcript : Supernus Pharmaceuticals, Inc. - Special Call |
Financials (USD)
Sales 2024 * | 600M | Sales 2025 * | 625M | Capitalization | 1.49B |
---|---|---|---|---|---|
Net income 2024 * | 14M | Net income 2025 * | -41M | EV / Sales 2024 * | 2.48 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.38 x |
P/E ratio 2024 * |
108
x | P/E ratio 2025 * |
-36.6
x | Employees | 652 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.98% |
Latest transcript on Supernus Pharmaceuticals, Inc.
1 day | +3.26% | ||
1 week | -1.76% | ||
Current month | -0.24% | ||
1 month | -6.58% | ||
3 months | -17.82% | ||
6 months | +1.83% | ||
Current year | -6.51% |
Managers | Title | Age | Since |
---|---|---|---|
Jack Khattar
FOU | Founder | 62 | 05-03-29 |
Timothy Dec
DFI | Director of Finance/CFO | 65 | 21-08-22 |
Frank Mottola
CTO | Chief Tech/Sci/R&D Officer | 52 | 04-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Georges Gemayel
BRD | Director/Board Member | 63 | 15-03-22 |
Charles Newhall
CHM | Chairman | 78 | 05-03-29 |
John Siebert
BRD | Director/Board Member | 84 | 10-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.94% | 28 M€ | -2.97% | ||
0.94% | 15 M€ | -3.21% | ||
0.38% | 26 M€ | -4.10% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-13 | 26.56 | -1.92% | 439 915 |
24-06-12 | 27.08 | +3.36% | 601,939 |
24-06-11 | 26.2 | +0.04% | 395,508 |
24-06-10 | 26.19 | -0.27% | 746,792 |
24-06-07 | 26.26 | -3.28% | 871,087 |
Delayed Quote Nasdaq, June 12, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.51% | 1.49B | |
+20.02% | 82.93B | |
+13.33% | 9.15B | |
+48.35% | 4.65B | |
-20.52% | 4.58B | |
+7.99% | 4.07B | |
+8.35% | 2.24B | |
-25.72% | 2.21B | |
+12.16% | 2.03B | |
-41.98% | 1.82B |
- Stock Market
- Equities
- SUPN Stock